Phaarmasia P/E Ratio
Current P/E Ratio
3.89
Low Valuation
Very Low - Potentially undervalued or facing challenges
Phaarmasia (PHRMASI) P/E ratio is 3.89 (Low), EPS (TTM) ₹25.74, current price ₹99.23 on BSE — Very Low - Potentially undervalued or facing challenges. Read PHRMASI dividend payout details for the complete payout history and dividend yield track record.
Current Valuation Metrics
P/E Ratio
3.89
Current Price
₹99.23
EPS (TTM)
₹25.74
Exchange
BSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
55.06
Sector Median
31.4
Sector Rank
#3 of 194
Sector Percentile
1.5%
PHRMASI P/E Ratio — Valuation Signal & Historical Context
Phaarmasia P/E 3.89 — signal: Undervalued. For live price, revenue and the complete fundamental profile, see PHRMASI screener.
- Stock appears undervalued with PE of 3.89, suggesting potential buying opportunity
- Trading at discount to sector average PE of 55.06
PHRMASI vs Healthcare Peers — P/E Ratio Comparison
Phaarmasia P/E 3.89 vs Healthcare average 55.06, median 31.4 — range 2.86–950.0.
Sector Average
55.06
Sector Median
31.4
Lowest P/E
2.86
Highest P/E
950.0
Companies
194
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.65 | ₹29 | Low |
| JFL Life Sciences | JFLLIFE | 4.64 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.69 | ₹7,502 | Low |
| Shelter Pharma | SHELTER | 5.32 | ₹50 | Low |
| Mono Pharmacare | MONOPHARMA | 6.02 | ₹19 | Low |
| Royal Sense | ROYAL | 7.4 | ₹51 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹79 | Low |
| Amwill Health Care | AMWILL | 7.71 | ₹88 | Low |
| Par Drugs & Chemical | PAR | 8.43 | ₹111 | Low |